New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Fortress Biotech, Inc.
FBIO
Shape
US Flag

NASDAQ

Unprofitable

Unprofitable

45M

Biotechnology

Next Earning date - 12 Nov 2024

45M

Biotechnology

Next Earning date - 12 Nov 2024

1.63USD
Shape0.02 ( 1.24%)
favorite-chart

Relative Strenght

10
favorite-chart

Volume Buzz

24%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

67%

Quote Panel

Shape
Updated October 6, 2024
1W 12.41 % 1M -8.43 % 3M -6.86 % 1Y -62.53 %

Key Metrics

Shape
  • Market Cap

    44.93M


  • Shares Outstanding

    27.56M


  • Share in Float

    21.73M


  • Dividende

    0


  • Earning Date

    12 Nov 2024


  • Price Target

    1.63


  • Average Volume

    455490


  • Beta

    1.797


  • Range

    1.24-4.95


  • Industry

    Biotechnology


  • Website

    https://www.fortressbiotech.com


  • Sector

    Healthcare


Fundamentals

Shape

N/A

P/E Ratio

0.54x

P/S Ratio

1.67x

P/B Ratio

4.1

Debt/Equity

-55.0%

Net Margin

$-27.7

EPS

How FBIO compares to sector?

P/E Ratio

Relative Strength

Shape

FBIO

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$141M

Shape849%

2025-Revenue

$2.56

Shape-251%

2025-EPS

$141M

Shape-407%

2025-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

Zacks Investment Research

downgrade

Previous: Not converted

2022-04-26

Now: Strong Sell

Earnings GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

N/A

-3.75
vs -3.90

Q4.22

arrow
arrow

N/A

-7.80
vs -5.66

Q1.23

arrow
arrow

N/A

-3.15
vs -2.70

Q2.23

arrow
arrow

N/A

-3.60
vs -3.60

Q3.23

arrow
arrow

N/A

-0.94
vs -3.75

Q4.23

arrow
arrow

N/A

-0.53
vs -7.80

Q1.24

arrow
arrow

N/A

-1.03
vs -3.15

Q2.24

arrow
arrow

N/A

-0.73
vs -3.60

Q3.24

arrow
arrow

N/A

-1.11
vs -0.94

Q4.24

arrow
arrow

N/A

-1.09
vs -0.53

Sales GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

-22%

16.5M  vs 21.1M

Q4.22

arrow
arrow

-10%

16.4M  vs 18.3M

Q1.23

arrow
arrow

-48%

12.4M  vs 23.9M

Q2.23

arrow
arrow

-8%

17.4M  vs 18.9M

Q3.23

arrow
arrow

+110%

34.8M  vs 16.5M

Q4.23

arrow
arrow

+22%

19.9M  vs 16.4M

Q1.24

arrow
arrow

+5%

13M  vs 12.4M

Q2.24

arrow
arrow

-15%

14.9M  vs 17.4M

Q3.24

arrow
arrow

-22%

27.1M  vs 34.8M

Q4.24

arrow
arrow

+22%

24.4M  vs 19.9M

Return on EquityShape

status-upQoQ

Q3.22

arrow
arrow

-29%

-0.29
vs -0.22

Q4.22

arrow
arrow

-138%

-1.38
vs -0.29

Q1.23

arrow
arrow

-59%

-0.59
vs -1.38

Q2.23

arrow
arrow

-134%

-1.34
vs -0.59

Q3.23

arrow
arrow

-30%

-0.30
vs -1.34

Q4.23

arrow
arrow

-41%

-0.41
vs -0.30

Q1.24

arrow
arrow

-77%

-0.77
vs -0.41

Q2.24

arrow
arrow

-75%

-0.75
vs -0.77

Institutionnal OwnershipShape

status-upQoQ

Q1.22

arrow
arrow

80

80
vs 85

-6%

Q2.22

arrow
arrow

62

62
vs 80

-22%

Q3.22

arrow
arrow

56

56
vs 62

-10%

Q4.22

arrow
arrow

48

48
vs 56

-14%

Q1.23

arrow
arrow

55

55
vs 48

15%

Q2.23

arrow
arrow

48

48
vs 55

-13%

Q3.23

arrow
arrow

47

47
vs 48

-2%

Q1.24

arrow
arrow

1

1
vs NA

NA

Earnings Growth

Latest News